Literature DB >> 18207447

Approaching the degradome in idiopathic pulmonary fibrosis.

Annie Pardo1, Moisés Selman, Naftali Kaminski.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a devastating, lethal and currently untreatable lung disorder of unknown etiology. It is characterized by epithelial injury and activation, fibroblastic foci formation, and exaggerated accumulation of extracellular matrix (ECM) with the destruction of the lung parenchyma. Despite important progress in our understanding of the general mechanisms involved in lung fibrogenesis, the pathogenesis of the IPF remains unclear. Although the irreversible and progressive fibrosis in the lung suggests a decrease in lung degradative machinery, an increasing body of evidence, primarily obtained by global gene expression studies, demonstrates a significant upregulation of degrading enzymes in IPF. In this context, this review will focus on some families of the degradome, a term proposed for the complete set of proteases that are expressed at a specific time by a cell, tissue or an organism. In particular, we will approach recent progress in our understanding of the behavior of two families of metalloproteases M10 and M12 which are significantly changed in the IPF lungs. In general, evidence highlights the increasing diversity in both substrates and functions of these enzymes and the complexity of the processes in which they are involved, and indicate a critical role in the abnormal remodeling of IPF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18207447     DOI: 10.1016/j.biocel.2007.11.020

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  42 in total

1.  Regulation of MMP10 expression by the transcription factor CHF1/Hey2 is mediated by multiple E boxes.

Authors:  Ling Wu; Wei-Ming Chien; Matthew E Hartman; Farid Moussavi-Harami; Yonggang Liu; Michael T Chin
Journal:  Biochem Biophys Res Commun       Date:  2011-11-03       Impact factor: 3.575

Review 2.  Molecular pathogenesis of infections caused by Legionella pneumophila.

Authors:  Hayley J Newton; Desmond K Y Ang; Ian R van Driel; Elizabeth L Hartland
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 3.  Matrix metalloproteinases in emphysema.

Authors:  Sina A Gharib; Anne M Manicone; William C Parks
Journal:  Matrix Biol       Date:  2018-03-23       Impact factor: 11.583

4.  Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis.

Authors:  Yong Zhou; Xiangwei Huang; Louise Hecker; Deepali Kurundkar; Ashish Kurundkar; Hui Liu; Tong-Huan Jin; Leena Desai; Karen Bernard; Victor J Thannickal
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

Review 5.  Interplay of extracellular matrix and leukocytes in lung inflammation.

Authors:  Thomas N Wight; Charles W Frevert; Jason S Debley; Stephen R Reeves; William C Parks; Steven F Ziegler
Journal:  Cell Immunol       Date:  2016-12-23       Impact factor: 4.868

6.  ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.

Authors:  Shennea Marriott; Rubin S Baskir; Christa Gaskill; Swapna Menon; Erica J Carrier; Janice Williams; Megha Talati; Karen Helm; Catherine E Alford; Jonathan A Kropski; James Loyd; Lisa Wheeler; Joyce Johnson; Eric Austin; Eva Nozik-Grayck; Barbara Meyrick; James D West; Dwight J Klemm; Susan M Majka
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-15       Impact factor: 4.249

7.  Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition.

Authors:  Lucas DeMaio; Stephen T Buckley; Manda S Krishnaveni; Per Flodby; Mickael Dubourd; Agnes Banfalvi; Yiming Xing; Carsten Ehrhardt; Parviz Minoo; Beiyun Zhou; Edward D Crandall; Zea Borok
Journal:  J Pathol       Date:  2011-12-09       Impact factor: 7.996

Review 8.  Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute.

Authors:  Victor J Thannickal; Craig A Henke; Jeffrey C Horowitz; Paul W Noble; Jesse Roman; Patricia J Sime; Yong Zhou; Rebecca G Wells; Eric S White; Daniel J Tschumperlin
Journal:  Am J Pathol       Date:  2014-04-13       Impact factor: 4.307

9.  MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis.

Authors:  Marco Checa; Víctor Ruiz; Martha Montaño; Rafael Velázquez-Cruz; Moisés Selman; Annie Pardo
Journal:  Hum Genet       Date:  2008-10-14       Impact factor: 4.132

10.  A review of current and novel therapies for idiopathic pulmonary fibrosis.

Authors:  Rokhsara Rafii; Maya M Juarez; Timothy E Albertson; Andrew L Chan
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.